A szívelégtelenség pacemakerkezelése - Reszinkronizációs terápia

Translated title of the contribution: Pacemaker therapy of heart failure - Cardiac resynchronozation therapy

Research output: Contribution to journalReview article


Cardiac resynchronization therapy is the therapy of choice in patients with severe congestive heart failure and intraventricular conduction disorder. The effiacy has been proven in several clinical studies. The therapy improves both objective and subjective clinical parameters significantly. Conventionally the therapy is indicated in severe drug refractory heart failure (NYHA III-IV) with optimal drug treatment, increased QRS duration (≥120 ms), echocardiographic parameters (left ventricular ejection fraction at most 35%). Implementation of new methods (tissue Doppler echocardiography, CT, MRI, electroanatomical mapping) can help to select potentially responding patients. Individual optimization of therapy can be performed with non-invasive and invasive methods, the efficacy can be improved even in responding patients. As the number of implantations has not reached the demand yet, it is necessary to improve the number of procedures performed.

Translated title of the contributionPacemaker therapy of heart failure - Cardiac resynchronozation therapy
Original languageHungarian
Pages (from-to)39-44
Number of pages6
Issue number1
Publication statusPublished - Jun 24 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pacemaker therapy of heart failure - Cardiac resynchronozation therapy'. Together they form a unique fingerprint.

  • Cite this